Dose requirement of d-tubocurarine and metocurine used for chronic respiratory paralysis in neonates. 1981

N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld

Nondepolarizing muscle relaxants are being used with increasing frequency in neonatal intensive care units. However, information concerning the chronic use of these agents and their dose requirements of d-tubocurarine and metocurine in neonates in whom respiratory paralysis was used as an adjunct to mechanical ventilation. All infants with gestational age greater than or equal to 38 wk demonstrated a dramatic daily increase in dose requirement of metocurine during the initial 8 days. However, infants with gestational age greater than or equal to 33 wk did not demonstrate a statistically significant daily increase in dose requirement. The 4 infants who received metocurine for more than 10 days exhibited a plateau of the dose requirement after 8-10 days. In contrast to the infants receiving metocurine, infants who received d-tubocurarine did not demonstrate a significant change in daily dose requirement. Four infants who received metocurine and four who received d-tubocurarine had acute renal failure and were not included in the above analysis. These infants had a significantly decreased dose requirement compared to the expected dose requirement for infants of comparable gestational age. There was no relationship between the dose requirement and the pH, serum potassium, or the use of aminoglycoside antibiotics.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009466 Neuromuscular Blocking Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. Neuromuscular Blocker,Neuromuscular Blocking Agent,Neuromuscular Blockers,Agent, Neuromuscular Blocking,Agents, Neuromuscular Blocking,Blocker, Neuromuscular,Blockers, Neuromuscular,Blocking Agent, Neuromuscular,Blocking Agents, Neuromuscular
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D012127 Respiratory Distress Syndrome, Newborn A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. Infantile Respiratory Distress Syndrome,Neonatal Respiratory Distress Syndrome,Respiratory Distress Syndrome, Infant
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014403 Tubocurarine A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae. Tubocurare,Tubocurarine Chloride,d-Tubocurare,d-Tubocurarine

Related Publications

N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
November 1979, Anesthesiology,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
January 1985, Anesthesia and analgesia,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
September 1982, Anesthesiology,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
October 1979, Anesthesiology,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
January 1979, Anesthesiology,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
August 1979, Anaesthesia and intensive care,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
January 1980, Anesthesia and analgesia,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
November 1979, British journal of anaesthesia,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
April 1980, Anesthesiology,
N Nussmeier, and G W Henry, and D C Stevens, and R L Schreiner, and J L Grosfeld
August 1980, Anesthesia and analgesia,
Copied contents to your clipboard!